Seladelpar Completed Phase 2 Trials for Primary Biliary Cholangitis Treatment

Back to Seladelpar
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02955602Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)